NORGES BANK - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 47 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$108,000
-19.4%
18,7340.0%0.00%
Q2 2015$134,000
+7.2%
18,7340.0%0.00%
Q1 2015$125,000
-6.7%
18,734
-16.4%
0.00%
Q4 2014$134,000
+20.7%
22,4000.0%0.00%
Q3 2014$111,000
-45.0%
22,400
-50.0%
0.00%
Q2 2014$202,000
+100.0%
44,800
+100.0%
0.00%
Q1 2014$101,000
-11.4%
22,4000.0%0.00%
Q4 2013$114,00022,4000.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,218,401$6,957,0004.07%
BARD ASSOCIATES INC 395,575$2,260,0000.21%
Ariel Investments 1,290,317$7,368,0000.08%
Ballew Advisors, Inc 5,557$31,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,400$1,173,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$68,0000.01%
Oakworth Capital, Inc. 3,052$17,0000.00%
Spark Investment Management LLC 10,800$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 878,348$5,015,0000.00%
Renaissance Technologies 381,471$2,178,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders